Founded in May 2018 in Delaware, MobiDrop is a fast growth BioTech startup based in Cambridge, Massachusetts. More than 60% of our core researchers and developers are Doctoral graduates of esteemed institutions, such as Harvard University, MIT, Tsinghua University, etc. MobiDrop focuses on the development, manufacture and sales of biotechnology applicable to precision medicine and digital health precision instruments, and related molecular diagnostic reagents. MobiDrop is working hard to bring the MobiNova single-cell sequencing solution and the MobiGaea All-in-One digital PCR solution to the market. MobiDrop’s mission is to pioneer accessible use of precision medicine through our leading diagnostic technology.